Happy Monday and welcome back to Week in Brief! We’ve got the latest genomics news here for you in one handy place – what better way to start the week?
Let’s start with this week’s biggest update…
Over 40 papers associated with The Human Cell Atlas consortium were published this week. According to the press release, the papers encompass everything from ‘how the placenta and skeleton form, changes during brain maturation, new gut and vascular cell states, lung responses to COVID-19, investigating how genetic variation impacts on disease, and many more.’ The findings have far-reaching implications for research, healthcare and beyond (Human Cell Atlas).
What’s going on in your gut?
Scientists have mapped 1.6 million gut cells, creating a detailed cellular atlas of the gastrointestinal tract. This resource identifies links between specific cell types and diseases, offering new targets for treatments of conditions like inflammatory bowel disease and colorectal cancer (Nature).
New work has revealed that coffee consumption significantly impacts the gut microbiome, potentially promoting a healthier and more diverse bacterial makeup. Coffee’s bioactive compounds may contribute to these health benefits, potentially aiding digestion and reducing inflammation (Nature Microbiology).
A combination of many genetic variants can influence health outcomes…
A study has revealed that individuals with rare neurodevelopmental disorders often carry a higher burden of common genetic variants associated with developmental conditions. In addition, common variation in the parents’ genes may influence a child’s risk of developing a neurodevelopmental condition, even if the child does not directly inherit these mutations (Nature).
Researchers have discovered that dilated cardiomyopathy is influenced by thousands of small genetic variations rather than single-gene mutations alone. They developed a polygenic risk score that could predict a person’s likelihood of developing the condition, offering new possibilities for precision medicine and early interventions (Nature Genetics).
And reproductive health has made headlines…
A study has revealed a specific genetic variant associated with early pregnancy loss in certain individuals, suggesting that premature egg aging is associated with miscarriage. This finding could pave the way for personalised diagnostics and treatments to support affected individuals (PNAS).
A nationwide study on reproductive carrier screening highlights its effectiveness in identifying genetic risks for rare conditions before pregnancy. This couple-based approach allows for informed family planning and the potential for early interventions (NEJM).
What else has been going on this week?
Researchers identified two broadly reactive human antibodies targeting a protein crucial in severe malaria infection. Using innovative organ-on-a-chip technology, they demonstrated the antibodies’ ability to prevent blood flow blockage caused by infected red blood cells, paving the way for vaccine or treatment development (Nature).
According to two studies, new genomic surveillance techniques have been used to track the spread and evolution of multidrug-resistant bacteria in Europe. This research aims to better understand the pathways of resistance and inform public health strategies to combat these dangerous pathogens (EuroSurveillance).
Finally, a recent study using single-cell sequencing has identified early cancer-like mutations in the breast cells of healthy women. These changes may represent the initial steps in the development of breast cancer (Nature Genetics).
Check out last week’s Week in Brief here.




